Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Spruce Street Capital LP
Form 13F · Q2 2026

Spruce Street Capital LP

CIK 2050194Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$510M
Reported book value
30
Positions
3
Quarters on record
Top 50
Positions

Spruce Street Capital LP — holdings

Top 30 positions of 30, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl918,070+20.6%$59M11.5%
2RLAY Relay Therapeutics Inc3.0M+0.0%$56M11.0%
3LBRX Lb Pharmaceuticals Inc1.4M+0.0%$45M8.8%
4RLMD Relmada Therapeutics Inc6.4M+2.1%$44M8.7%
5ANRO Alto Neuroscience Inc1.4M+2.1%$36M7.0%
6DNTH Dianthus Therapeutics Inc354,816−4.9%$35M6.8%
7ALKS Alkermes Plc543,876+71.0%$28M5.6%
8SVRA Savara Inc3.5M+2.1%$21M4.2%
9PCVX Vaxcyte Inc306,047+24.6%$18M3.5%
10ELVN Enliven Therapeutics Inc329,006+0.0%$17M3.3%
11ENTA Enanta Pharmaceuticals Inc1.1M+16.7%$16M3.1%
12CATX Perspective Therapeutics Inc3.7M+40.6%$13M2.5%
13INFLARX NV Inflarx Nv5.4M—$12M2.4%
14SRZN Surrozen Inc432,040+0.0%$11M2.2%
15ALMS Alumis Inc392,574+0.0%$11M2.2%
16IPSC Century Therapeutics Inc4.1M+0.0%$10M2.0%
17NERV Minerva Neurosciences Inc1.7M+0.0%$9M1.8%
18SABS Sab Biotherapeutics Inc2.2M+0.0%$9M1.7%
19ANTX An2 Therapeutics Inc1.7M+0.0%$8M1.6%
20ERAS Erasca Inc422,543+0.0%$8M1.5%
21IKT Inhibikase Therapeutics Inc3.6M+0.0%$7M1.4%
22RACC Research Alliance Corp Iii500,000—$5M1.0%
23HLXC Helix Acquisition Corp Iii500,000+0.0%$5M1.0%
24ZLAB Zai Lab Ltd279,110—$5M1.0%
25QUIT Achieve Life Science Inc736,637—$5M0.9%
26LXEO Lexeo Therapeutics Inc928,593+0.0%$4M0.8%
27ALEC Alector Inc2.1M+0.0%$4M0.8%
28LONA Leonabio Inc393,701+0.0%$4M0.7%
29CRVS Corvus Pharmaceuticals Inc231,585+0.0%$3M0.7%
30JATT Jatt Ii Acquisition Corp160,000—$2M0.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.